Clearside Biomedical/ US1850631045 /
| 10/3/2023 9:30:54 PM | Chg. - | Volume | Bid3:45:00 PM | Ask3:45:00 PM | High | Low |
|---|---|---|---|---|---|---|
| 0.86USD | - | 500 Turnover: 428.17 |
0.76Bid Size: 100 | 0.92Ask Size: 100 | 0.86 | 0.85 |
GlobeNewswire
3/10/2022
Clearside Biomedical Announces Fourth Quarter and Full Year 2021 Financial Results and Provides Corp...
GlobeNewswire
3/3/2022
Clearside Biomedical Appoints Benjamin R. Yerxa, Ph.D. to its Board of Directors
GlobeNewswire
3/1/2022
Clearside Biomedical to Participate in Two Upcoming Investor Conferences in March 2022
GlobeNewswire
2/25/2022
Clearside Biomedical to Report Fourth Quarter and Full Year 2021 Financial Results and Provide Corpo...
GlobeNewswire
2/14/2022
Clearside Biomedical’s Suprachoroidal Injection Platform Featured at the Angiogenesis, Exudation, an...
GlobeNewswire
2/7/2022
Adverum Biotechnologies Appoints Richard Beckman M.D. as Chief Medical Officer
GlobeNewswire
2/2/2022
Clearside Biomedical’s Suprachoroidal Injection Platform to be Featured at the Angiogenesis, Exudati...
GlobeNewswire
12/21/2021
Clearside Biomedical Announces Positive Safety Results from OASIS Phase 1/2a Clinical Trial of CLS-A...
GlobeNewswire
11/16/2021
Clearside Biomedical Features FDA-Approved XIPERE™ in Multiple Presentations at the American Academy...
GlobeNewswire
11/11/2021
Clearside Biomedical to Participate in Upcoming Investor Events in November and December 2021
GlobeNewswire
11/10/2021
Clearside Biomedical Announces Third Quarter 2021 Financial Results and Provides Corporate Update
GlobeNewswire
10/28/2021
Clearside Biomedical to Report Third Quarter 2021 Financial Results and Provide Corporate Update on ...
GlobeNewswire
10/13/2021
Clearside Biomedical Delivers Podium and Poster Presentations at the American Society of Retina Spec...
GlobeNewswire
10/5/2021
Newly Formed Lanier Biotherapeutics Enters into License Agreement with Alloy Therapeutics
GlobeNewswire
10/4/2021
Clearside Biomedical Announces Multiple Poster Presentations at the Retina Society 54th Annual Scien...
GlobeNewswire
9/21/2021
Clearside Biomedical Announces Completion of Dosing in Cohort 2 of Phase 1/2a Clinical Trial of CLS-...
GlobeNewswire
9/9/2021
Clearside Biomedical Expands XIPERE™ License Agreement with Arctic Vision to Include Australia, New...
GlobeNewswire
8/23/2021
Clearside Biomedical to Present at the Ophthalmology Futures European 2021 Virtual Retina Forum
GlobeNewswire
8/10/2021
Clearside Biomedical Announces Second Quarter 2021 Financial Results and Provides Corporate Update
GlobeNewswire
8/4/2021
Clearside Biomedical to Participate in Two Upcoming Investor Conferences in August 2021
GlobeNewswire
7/27/2021
Clearside Biomedical to Report Second Quarter 2021 Financial Results and Provide Corporate Update on...
GlobeNewswire
6/15/2021
Clearside Biomedical Announces Positive Safety Results from Cohort 1 of OASIS Phase 1/2a Clinical Tr...
GlobeNewswire
6/9/2021
Clearside Biomedical to Participate in Two Upcoming Investor Conferences in June 2021